Zobrazeno 1 - 10
of 494
pro vyhledávání: '"Clara Santos"'
Autor:
Sofía González-Rueda, Osvaldo García-Pérez, Myrna Luna-Gutiérrez, Blanca Ocampo-García, Clara Santos-Cuevas, Gerardo Ramírez-Nava, Joel Vargas-Ahumada, Erika Azorín-Vega, Guillermina Ferro-Flores, Laura Meléndez-Alafort
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1358 (2024)
Background/Objectives: Prostate cancer (PC) represents the second most diagnosed form of cancer in men on a global scale. Despite the theranostic efficacy of prostate-specific membrane antigen (PSMA) radioligands, there is a spectrum of PC disease in
Externí odkaz:
https://doaj.org/article/0190cb737f5f4444bdf0d5e850ae0794
Autor:
Diana Trujillo-Benítez, Myrna Luna-Gutiérrez, José G. Aguirre-De Paz, Pedro Cruz-Nova, Gerardo Bravo-Villegas, Joel E. Vargas-Ahumada, Paola Vallejo-Armenta, Enrique Morales-Avila, Nallely Jiménez-Mancilla, Rigoberto Oros-Pantoja, Clara Santos-Cuevas, Erika Azorín-Vega, Blanca Ocampo-García, Guillermina Ferro-Flores
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 532 (2024)
Recently, we reported a new fibroblast activation protein (FAP) inhibitor radiopharmaceutical based on the 99mTc-((R)-1-((6-hydrazinylnicotinoyl)-D-alanyl) pyrrolidin-2-yl) boronic acid (99mTc-HYNIC-D-Alanine-BoroPro)(99mTc-HYNIC-iFAP) structure for
Externí odkaz:
https://doaj.org/article/0fdb43edc9aa47f6b9827a930acef9fb
Autor:
Pedro Cruz-Nova, Brenda Gibbens-Bandala, Alejandra Ancira-Cortez, Gerardo Ramírez-Nava, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Blanca Ocampo-García
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionMore than 1.9 million new cases of colorectal cancer and 935,000 deaths were estimated to have occurred worldwide in 2020. Therapies for metastatic colorectal cancer include cytotoxic chemotherapy and targeted therapies in multiple lines
Externí odkaz:
https://doaj.org/article/40823603a990461e9856085094bdbe1f
Autor:
Guillermina Ferro-Flores, Blanca Ocampo-García, Pedro Cruz-Nova, Myrna Luna-Gutiérrez, Gerardo Bravo-Villegas, Erika Azorín-Vega, Nallely Jiménez-Mancilla, Emiliano Michel-Sánchez, Osvaldo García-Pérez, Nancy Lara-Almazán, Clara Santos-Cuevas
Publikováno v:
Pharmaceutics, Vol 15, Iss 12, p 2662 (2023)
Recent cancer therapies have focused on reducing immune suppression in the tumor microenvironment to prevent cancer progression and metastasis. PD-1 is a checkpoint protein that stops the immune response and is expressed on immune T cells. Cancer cel
Externí odkaz:
https://doaj.org/article/2e6c59ca67464c6e85d204f50551568c
Autor:
Myrna Luna-Gutiérrez, Rodrigo Hernández-Ramírez, Airam Soto-Abundiz, Osvaldo García-Pérez, Alejandra Ancira-Cortez, Sergio López-Buenrostro, Brenda Gibbens-Bandala, Irma Soldevilla-Gallardo, Nancy Lara-Almazán, Melissa Rojas-Pérez, Blanca Ocampo-García, Erika Azorín-Vega, Clara Santos-Cuevas, Guillermina Ferro-Flores
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1988 (2023)
177Lu-iPSMA is a novel radioligand developed at ININ-Mexico with a high affinity for the PSMA protein heavily expressed in cancer cells of approximately 95% of patients with metastatic castration-resistant prostate cancer (mCRPC). 177Lu-DOTATOC is a
Externí odkaz:
https://doaj.org/article/5d0dae5e07b64950ba7b769e4bd92c95
Autor:
Catarina Isabel Ribeiro, Clara Santos, Clara Almeida, Teresa Melo, David Tente, João Carlos Fernandes
Publikováno v:
Journal of Nephropathology, Vol 11, Iss 3, Pp e15957-e15957 (2022)
Type II mixed cryoglobulinemia is a systemic disease mediated by immune complexes. Renal involvement is present in almost one third of the cases and the membranoprolifer-ative pattern is the most common histological presentation. In turn, in Waldenst
Externí odkaz:
https://doaj.org/article/c2e7701460264ca7916d4d86777be6a2
Publikováno v:
Brazilian Journal of Nephrology, Vol 43, Iss 1, Pp 88-102 (2021)
Abstract Pregnancy requires several physiological adaptations from the maternal organism, including modifications in the glomerular filtration rate and renal excretion of several products. Chronic kidney disease (CKD) can negatively affect these modi
Externí odkaz:
https://doaj.org/article/6b439699504549c5a392bf966582283e
Autor:
Debora Carpanese, Guillermina Ferro-Flores, Blanca Ocampo-Garcia, Clara Santos-Cuevas, Nicola Salvarese, Mariangela Figini, Giulio Fracasso, Laura De Nardo, Cristina Bolzati, Antonio Rosato, Laura Meléndez-Alafort
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract The clinical translation of theranostic 177Lu-radiopharmaceuticals based on inhibitors of the prostate-specific membrane antigen (PSMA) has demonstrated positive clinical responses in patients with advanced prostate cancer (PCa). However, ch
Externí odkaz:
https://doaj.org/article/9b2d1ad6b66740dab5e3f6564255938b
Autor:
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-García, Clara Santos-Cuevas, Enrique Morales-Avila, Guillermina Ferro-Flores
Publikováno v:
Nanomaterials, Vol 12, Iss 23, p 4181 (2022)
The fibroblast activation protein (FAP) is heavily expressed in fibroblasts associated with the tumor microenvironment, while the prostate-specific membrane antigen (PSMA) is expressed in the neovasculature of malignant angiogenic processes. Previous
Externí odkaz:
https://doaj.org/article/a45ed9b713f1416fb1cfeaa2c76bf181
Autor:
Liliana Aranda-Lara, Keila Isaac-Olivé, Blanca Ocampo-García, Guillermina Ferro-Flores, Carlos González-Romero, Alfredo Mercado-López, Rodrigo García-Marín, Clara Santos-Cuevas, José A. Estrada, Enrique Morales-Avila
Publikováno v:
Molecules, Vol 27, Iss 20, p 7046 (2022)
Reconstituted high-density lipoproteins (rHDLs) can transport and specifically release drugs and imaging agents, mediated by the Scavenger Receptor Type B1 (SR-B1) present in a wide variety of tumor cells, providing convenient platforms for developin
Externí odkaz:
https://doaj.org/article/c20b2686f31244edb4afc72e6a0b0838